Skip to content

Effectiveness of pcychoeducation program in bipollar patients

Effectiveness of group pcycho-education program on bipolar patients' adherence to drug, insight and quality of life

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
IRCT
Registry ID
IRCT2016061928533N1
Enrollment
20
Registered
2016-08-13
Start date
2016-04-29
Completion date
Unknown
Last updated
2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Condition 1: bipollar disorder. Condition 2: bipollar disorder. Bipolar affective disorder, currently in remission Bipolar affective disorder, currently in remission

Interventions

Intervention 1: Group 1: A psycho-educational program was conducted for the psycho-educational group( Combined intervention pcychoeducation Plus Medication) during 5 weekly sessions. Intervention 2: g
Treatment - Other
Group 1: A psycho-educational program was conducted for the psycho-educational group( Combined intervention pcychoeducation Plus Medication) during 5 weekly sessions.
group (2): Pharmachotherapy They received as usual treatment (Medication)

Sponsors

Medical Science Of Zanjan
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
18 Years to 50 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria : being diagnosed as bipolar disorder based on diagnostic interview and SCID-I/CV test results. Being in the age range of 18 to 50, having the euthymic mood during the study (score less than or equal to 7 for Hamilton scale and score less than or equal to 6 for Young Mania scale). Exclusion criteria : being at the acute phase of the disease or being an active drug abuser, having mental retardation, having the full criteria for Scizofrenia diagnosed by psychiatrist and according to SCID-I.

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
Adherence to drug. Timepoint: before therapy, after therapy, after a month. Method of measurement: morisky medication adherence scale.

Secondary

MeasureTime frame
Insight and quality of life. Timepoint: before therapy, after therapy, a month after therpy. Method of measurement: mood disorder insight scale, world health organization questionaire.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactArezu Nahid sahlan

Zanjan University of Medical Science

Arezu.nahid@zums.ac.ir+98 41 3266 4793

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026